We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.86%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$421M
AUM Growth
+$85.4M
(+25%)
Cap. Flow
+$55.9M
Cap. Flow
% of AUM
13.26%
Top 10 Holdings %
Top 10 Hldgs %
50.23%
Holding
96
New
22
Increased
24
Reduced
22
Closed
7
Top Buys
| 1 |
Nurix Therapeutics
NRIX
|
+$11.6M |
| 2 |
Revolution Medicines
RVMD
|
+$5.77M |
| 3 |
Protalix BioTherapeutics
PLX
|
+$5.61M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$5.51M |
| 5 |
Adicet Bio
ACET
|
+$4.41M |
Top Sells
| 1 |
FLNA
Filana Therapeutics
FLNA
|
+$3.07M |
| 2 |
Neuronetics
STIM
|
+$2.91M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$2.9M |
| 4 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
+$2.46M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$1.95M |
Sector Composition
| 1 | Healthcare | 90.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$161M
| $91.9M | 21.81% |
13,680,554
| – | – |
|
2
Fate Therapeutics
FATE
$338M
| $25.9M | 6.15% |
314,360
-20,000
| -6% | -$1.92M |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $20.2M | 4.8% |
207,911
+1,000
| +0.5% | +$99.8K |
|
|
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $15M | 3.57% |
587,756
| – | – |
|
|
SAGE
5
DELISTED
Sage Therapeutics
SAGE
| $13.6M | 3.22% |
181,306
| – | – |
|
|
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $11.5M | 2.72% |
181,467
+120,000
| +195% | +$5.51M |
|
|
7
Nurix Therapeutics
NRIX
$2.44B
| $9.52M | 2.26% |
+306,320
| New | +$11.6M |
|
8
AtriCure
ATRC
$1.76B
| $8.42M | 2% |
128,529
-4,700
| -4% | -$289K |
|
|
AFMD
9
DELISTED
Affimed
AFMD
| $7.83M | 1.86% |
98,986
+11,550
| +13% | +$750K |
|
10
IDEAYA Biosciences
IDYA
$3.54B
| $7.79M | 1.85% |
331,661
| – | – |
|
11
DexCom
DXCM
$28.6B
| $7.6M | 1.8% |
84,552
| – | – |
|
12
Xenon Pharmaceuticals
XENE
$6.52B
| $7.28M | 1.73% |
406,535
+60,000
| +17% | +$1.02M |
|
13
ProQR Therapeutics
PRQR
$243M
| $7.27M | 1.73% |
1,100,000
-137,400
| -11% | -$702K |
|
|
14
Neurocrine Biosciences
NBIX
$17.2B
| $7.16M | 1.7% |
73,655
-18,553
| -20% | -$1.95M |
|
|
15
Revolution Medicines
RVMD
$39.2B
| $6.94M | 1.65% |
151,231
+128,731
| +572% | +$5.77M |
|
|
BHVN
16
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.4M | 1.52% |
93,600
+11,500
| +14% | +$930K |
|
17
iShares Biotechnology ETF
IBB
$9.2B
| $6.08M | 1.44% |
40,400
-7,000
| -15% | -$1.11M |
|
|
LKFT
18
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $5.79M | 1.37% |
75,175
-5,200
| -6% | -$479K |
|
|
KRTX
19
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.77M | 1.37% |
48,000
+31,332
| +188% | +$3.55M |
|
|
CSII
20
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.74M | 1.36% |
149,700
-1,500
| -1% | -$63.8K |
|
|
TVRD
21
Tvardi Therapeutics
TVRD
$29.3M
| $5.68M | 1.35% |
7,262
| – | – |
|
|
22
Protalix BioTherapeutics
PLX
$188M
| $5.37M | 1.28% |
+1,204,825
| New | +$5.61M |
|
|
ARNA
23
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.32M | 1.26% |
76,715
-100
| -0.1% | -$7.7K |
|
|
24
Adicet Bio
ACET
$80.9M
| $5.04M | 1.2% |
24,067
+19,218
| +396% | +$4.41M |
|
|
AERI
25
DELISTED
Aerie Pharmaceuticals
AERI
| $4.93M | 1.17% |
275,840
-12,600
| -4% | -$218K |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML